177Lu-Dotatate Therapy for the treatment of metastatic neuroendocrine tumours in a patient on haemodialysis - Case report

被引：0
|
作者：
Kalogianni, E. [1 ]
Ruiz, D. [1 ]
Chakravartty, R. [2 ]
Corcoran, B. [1 ]
Devlin, L. [1 ]
Mulholland, N. [1 ]
Vivian, G. [1 ]
机构：
[1] Kings Coll London, London WC2R 2LS, England
[2] Royal Free Hosp, London NW3 2QG, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P600
引用
收藏
页码：S531 / S531
页数：1
相关论文
共 50 条
  • [1] Lu-177-Dotatate therapy for the treatment of metastatic neuroendocrine tumours in a patient on haemodialysis - dosimetric considerations
    Kalogianni, Eleni
    Ruiz, Danielle Louise
    Corcoran, Benjamin James
    Devlin, Lindsey Ann
    Vivian, Gillian Claire
    Mulholland, Nicola Jane
    [J]. BJR CASE REPORTS, 2015, 1 (03):
  • [2] 177Lu-DOTATATE Quantification for Patient Personalised Dosimetry in Therapy of Neuroendocrine Tumours
    Rodrigues, C.
    Ferreira, P.
    Oliveira, F. P. M.
    Silva, A.
    Peralta, L.
    Costa, D. C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S656 - S656
  • [3] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [4] 177Lu-Dotatate for midgut neuroendocrine tumours
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2017, 18 (02): : E74 - E74
  • [5] 177Lu-DOTATATE treatment in neuroendocrine tumours. A preliminary study
    Hervas, I.
    Bello, P.
    Falgas, M.
    del Olmo, M. I.
    Torres, I.
    Olivas, C.
    Vera, V.
    Olivan, P.
    Yepes, A. M.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (02): : 91 - 98
  • [6] Individualized dosimetry in patients with metastatic neuroendocrine tumours after treatment with 177Lu-Dotatate targeted radionuclide therapy
    Kalogianni, E.
    Dunlop, A.
    Corcoran, B.
    Hooker, C.
    Devlin, L.
    Mulholland, N.
    Vivian, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S308 - S308
  • [7] Neuroendocrine Tumor Therapy: 177Lu-DOTATATE
    Mittra, Erik S.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) : 278 - 285
  • [8] Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
    Sundlov, Anna
    Sjogreen-Gleisner, Katarina
    Svensson, Johanna
    Ljungberg, Michael
    Olsson, Tomas
    Bernhardt, Peter
    Tennvall, Jan
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1480 - 1489
  • [9] Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
    Anna Sundlöv
    Katarina Sjögreen-Gleisner
    Johanna Svensson
    Michael Ljungberg
    Tomas Olsson
    Peter Bernhardt
    Jan Tennvall
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1480 - 1489
  • [10] A Case of Metastatic Thymoma Responsive to Treatment With 177Lu-DOTATATE
    Halperin, Reut
    Urban, Damien
    Tirosh, Amit
    [J]. CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : E190 - E192
12345